4 ms·
Few competitors, no reason to innovate. And they're charging $8-12,000 for a new pump setup. That was our experience 5 years ago with Medtronic. Not a single
by GiorgioG 8y ago
Few competitors, no reason to innovate. And they're charging $8-12,000 for a new pump setup. That was our experience 5 years ago with Medtronic. Not a single update in 4 years with our son's 530g pump. With his new pump (from Tandem) we're expecting a pretty big software patch/upgrade later this year. Beta Bionics is working on their artificial pancreas (dual hormone) that should be out next year. So newer/more-nimble players are forcing the bigger companies to start innovating. Having said that, it never comes soon enough ;)
- ZucchiniZe 8y agoI got a chance to try out the beta bionics artificial pancreas in a research trial and it is a truly new innovation in this field, it lifted about 90% of the constant thinking about bolus and blood sugar from me and allowed me to live my life. It truly deserves all the hype that it is getting.
- GiorgioG 8y agoWow that's great to hear! Was it insulin-only or did it also have glucagon onboard? I know they're working towards releasing the insulin-only version first. I can't wait for the dual-hormone version to become available. It'll allow my wife and I to sleep through the night without worrying that our son won't wake up when he drops too low.
- thecosas 8y agoSidebar: Tandem's Q1 2019 results came out today and they're doing pretty dang well. http://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-announces-first-quarter-2019-financial http://investor.tandemdiabetes.com/news-releases/news-releas... Operating margin is still negative, but it's improved tremendously year over year.